# Smart Cyano

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/smart-cyano

- Industry: Biotechnology
- Headquarters: Qingdao, China
- Website: www.marinecyano.com
- Latest round: Series A (Feb 9, 2023)
- Investors on record: 2

## About

Based in Shenzhen, China and founded in 2018, Qingdao Zhongke Lanzhi Biotechnology Development Co., Ltd., trading under the name Smart Cyano, operates as a natural algae active substance developer, integrating the research and development, production and sales of bioactive raw materials. The company has been granted certificates such as ISO9001 quality management system certification, ISO22716 cosmetic international quality management system certification, glycerol glucoside corporate standard, and EU COSMOS pure natural certification. The founder team members were from Qingdao Institute of Bioenergy and Processes, Chinese Academy of Sciences. In June 2025, it closed a round of pre-series B funding. The core product of the company is GLYCERYL GLUCOSIDE, abbreviated as GG. GG is a glycoside with multiple physiological effects. GG products have a variety of cellular physiological effects such as anti-aging and wrinkle removal, anti-inflammatory and allergy relief, long-lasting moisturizing, hair growth and nourishment, prevention of dental caries. The products can be used in cosmetics, health food and pharmaceutical products. The company generates revenue though the sales of its pharmaceutical products. The company will use the funding from the latest series B round to promote the industrialization-related businesses in China for green biomanufacturing technologies for bioactive molecules and bulk chemicals, and accelerate the construction of a talent team.

## Funding rounds

- Series A, Feb 9, 2023 — Shangshi Fund, Golden Malus Fund

## Investors

- Shangshi Fund (https://capitalatlas.ai/funds/shangshi-fund) — Series A
- Golden Malus Fund — Series A